Central Europe Online
SEE OTHER BRANDS

The top news stories from Europe

Central Europe Online : Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Central Europe Online .

Press releases published on April 1, 2025

Eco-friendly Bamboo Drinking Straws: A Sustainable Alternative to Plastic Pollution

Eco-friendly Bamboo Drinking Straws: A Sustainable Alternative to Plastic Pollution

Innovative Solution from Bamboo's Flexibility and Toughness NANJING, CHINA, March 31, 2025 /⁨EINPresswire.com⁩/ -- The global issue of plastic pollution has led to a search for sustainable alternatives to disposable plastic products. One of the most …

Former Number 10 Policy Expert Shares Insights on Effective Policy Influence

Former Number 10 Policy Expert Shares Insights on Effective Policy Influence

LONDON, GREATER LONDON, UNITED KINGDOM, April 1, 2025 /⁨EINPresswire.com⁩/ -- An interview with James Nation, former Deputy Director of the Number 10 Policy Unit and Special Advisor to the Chancellor of the Exchequer, provides a rare glimpse into the inner …

Stellantis Annual General Meeting Live Webcast Available

Stellantis Annual General Meeting Live Webcast Available

Stellantis Annual General Meeting Live Webcast Available AMSTERDAM, April 1, 2025 – Stellantis N.V. announced today that a link for the live webcast of its Annual General Meeting for the approval of Stellantis N.V.’s 2024 financial statements will be made …

GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)

GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)

The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns seen in the data reviewed Interim results demonstrate GRI-0621 to be safe and well-tolerated in the first 12 patients evaluated …

La recette, une étape incontournable dans un projet IT

La recette, une étape incontournable dans un projet IT

Garantir la conformité aux besoins métiers et la robustesse du système est un enjeu majeur dans tout projet de développement informatique.  La phase de recettage constitue une étape critique dans cette démarche car elle permet d'assurer que la solution …

Societe Generale offer to purchase certain of its debt securities

Societe Generale offer to purchase certain of its debt securities

SOCIETE GENERALE OFFER TO PURCHASE CERTAIN OF ITS DEBT SECURITIES Press release Paris, April 1, 2025 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE OR TO WHOM IT IS UNLAWFUL TO RELEASE …

Société Générale lance une offre de rachat sur certains titres de dette

Société Générale lance une offre de rachat sur certains titres de dette

SOCIÉTÉ GÉNÉRALE LANCE UNE OFFRE DE RACHAT SUR CERTAINS TITRES DE DETTE Communiqué de presse Paris, le 1 avril 2025 NON DESTINÉ À ÊTRE PUBLIÉ, DIFFUSÉ OU DISTRIBUÉ A TOUT INDIVIDU SITUÉ OU RÉSIDENT DANS UNE JURIDICTION OÙ OU À QUI IL EST ILLÉGAL DE PUBLIER …

Holding(s) in Company

Holding(s) in Company

Reykjavík, April 01, 2025 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)   1a. Identity of the issuer or the …

Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson’s Disease at AD/PD 2025

Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson’s Disease at AD/PD 2025

Solengepras showed evidence of potential benefit in functional and non-motor symptoms versus placebo as measured by MDS-UPRDS Parts I, II, NMSS, and ESS, consistent with its novel non-dopaminergic mechanism of action This investigational treatment was …

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind’s innovative, psychedelic-derived, MEAI-based compound in individuals with alcohol addiction Vancouver, Canada, April 01, 2025 (GLOBE NEWSWIRE) -- Clearmind …

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update

Lab network revenue increased by 33% year over year, reflecting strong demand for ColoAlert® in EuropeOperating loss decreased by 30% and net loss by 18%, driven by targeted cost reductions and a sharper strategic focusBERKELEY, Calif. and MAINZ, Germany, …

Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress

Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress

CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of …

Merus to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

Merus to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics®, Triclonics® and ADClonics …

Brera Holdings Board Advisor Giuseppe Rossi Honored with Emotional Football Farewell at Historic Stadio Artemio Franchi

Brera Holdings Board Advisor Giuseppe Rossi Honored with Emotional Football Farewell at Historic Stadio Artemio Franchi

Brera Holdings sponsored the Pepito Day event, with Brera club logos pictured on the LED screens. Giuseppe Rossi, Brera board advisor, pictured in the center of the photograph Dublin, Ireland and Florence, Italy, April 01, 2025 (GLOBE NEWSWIRE) -- Brera …

Merus participera à une discussion informelle lors de la 24e conférence annuelle Needham Virtual Healthcare

Merus participera à une discussion informelle lors de la 24e conférence annuelle Needham Virtual Healthcare

UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachussets, 01 avr. 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), entreprise spécialisée en oncologie développant des anticorps de pleine longueur multispécifiques et des conjugués anticorps-médicament …

Skyharbour Partner Company Terra Clean Energy Completes Winter Drill Program with Encouraging Results and Prepares a Significant Summer Drill Program at the South Falcon East Uranium Project

Skyharbour Partner Company Terra Clean Energy Completes Winter Drill Program with Encouraging Results and Prepares a Significant Summer Drill Program at the South Falcon East Uranium Project

Vancouver, BC, April 01, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to announce that partner company Terra Clean Energy Corp. (“Terra”, previously Tisdale …

Evaxion announces business update and full year 2024 financial results

Evaxion announces business update and full year 2024 financial results

COPENHAGEN, Denmark, April 1, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces full year 2024 financial results. …

Context Therapeutics to Participate in Upcoming Investor Conferences

Context Therapeutics to Participate in Upcoming Investor Conferences

PHILADELPHIA, April 01, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its …

iPronics dévoile le premier commutateur de circuits optiques en photonique sur silicium pour la transformation des réseaux optiques des centres de données pilotés par l’IA

iPronics dévoile le premier commutateur de circuits optiques en photonique sur silicium pour la transformation des réseaux optiques des centres de données pilotés par l’IA

VALENCE, Espagne, 01 avr. 2025 (GLOBE NEWSWIRE) -- iPronics, leader de la photonique programmable par logiciel, a annoncé ce jour le lancement de son Optical Networking Engine, ONE-32, le premier commutateur de circuits optiques (OCS) au monde à base de …

SynOx Therapeutics Announces Board Chair Transition to Align with Advancing Regulatory and Commercialization Strategy

SynOx Therapeutics Announces Board Chair Transition to Align with Advancing Regulatory and Commercialization Strategy

Newly Appointed Board Chair, Philip Astley-Sparke, Brings Transatlantic Late-Stage Development, Regulatory and Commercial Expertise Strengthened Leadership and Expanded U.S. Presence Positions SynOx for Regulatory Filings and Commercialization of …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service